179 related articles for article (PubMed ID: 3098192)
1. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.
Maddison PJ; Skinner RP; Pereira RS; Black CM; Ansell BM; Jayson MI; Rowell NR; Welsh KI
Ann Rheum Dis; 1986 Oct; 45(10):793-9. PubMed ID: 3098192
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.
Barnett AJ; McNeilage LJ
Ann Rheum Dis; 1993 May; 52(5):365-8. PubMed ID: 8323384
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
6. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
[TBL] [Abstract][Full Text] [Related]
7. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.
Maddison PJ; Stephens C; Briggs D; Welsh KI; Harvey G; Whyte J; McHugh N; Black CM
Medicine (Baltimore); 1993 Mar; 72(2):103-12. PubMed ID: 8479323
[TBL] [Abstract][Full Text] [Related]
9. Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.
French MA; Harrison G; Penning CA; Cunningham J; Hughes P; Rowell NR
Ann Rheum Dis; 1985 Feb; 44(2):89-92. PubMed ID: 3919660
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
11. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants.
Manolios N; Dunckley H; Chivers T; Brooks P; Englert H
J Rheumatol; 1995 Jan; 22(1):85-92. PubMed ID: 7699689
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
Arora-Singh RK; Assassi S; del Junco DJ; Arnett FC; Perry M; Irfan U; Sharif R; Mattar T; Mayes MD
J Autoimmun; 2010 Aug; 35(1):52-7. PubMed ID: 20223638
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
15. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies.
Cassani F; Tosti A; Bianchi FB; Fusconi M; Selleri L; Baffoni L; Veronesi S; Volta U; Lenzi M; Pisi E
Clin Exp Rheumatol; 1987; 5(1):23-8. PubMed ID: 3109797
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
17. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
Deng JS; Bair LW; Medsger TA; Sontheimer RA
Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
[TBL] [Abstract][Full Text] [Related]
18. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
Bernstein RM; Steigerwald JC; Tan EM
Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
20. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]